Men's Health in Detroit

Men’s Health in Detroit

There are a number of preventive services that men need to stay healthy as they age. Basic items include annual flu shots and annual blood work to check for cholesterol levels. Checking your blood pressure, height, and weight is also important to screen for hypertension and obesity.

As men age, more complex screening tests are needed. For example, at age 50, men need a Colonoscopy to check for colon cancer. Men who smoke require an ultrasound of the abdominal aorta to rule out an aortic aneurysm at age 65. Men who smoke the equivalent of 1 pack per day for 20 years would benefit from a CT scan of the lungs to rule out lung cancer starting at age 50. From the United States Preventive Services Task Force:

The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults ages 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years.

If you’d like us to help you coordinate these tests by becoming your primary care doctor, you can sign up on our website, here.

Men’s Health Event in Detroit

On the note of preventive service, this weekend, the MIU Men’s Health Foundation is providing an opportunity to do check some of these screening tests off of your list. This Saturday, September 26th, the foundation is hosting its 10th annual Men’s Health Event at the Michigan State Fairgrounds.  The event will run from 9AM-4PM and the entrance is located at 770 W. State Fair, in Highland Park.  To avoid waiting in a line, they do recommend scheduling a time for your drive-through by registering at this website.

All Metro Detroit-area men, ages 18 years and older, with or without insurance, can participate in this completely drive-through event.  All services are completely free, and include vital screenings, a bloodwork panel, flu vaccinations, FIT kits for colorectal cancer screening, COVID-19 nasal swab testing, and HIV testing.  All testing will be administered without participants needing to leave their vehicles.  Blood work results will be texted back, unless other arrangements are made at the event, and you do not need to be fasting for the blood draw.  More information about the event is available here. 

The Debate on Prostate Cancer Screening in Detroit

Prostate Cancer screening is a double-edged sword. Prostate specific antigen is a protein made by the prostate that can become elevated during prostate cancer. It can be easily tested with a blood draw. Just because it can be easily tested, doesn’t mean it should be tested. Usually, PSA testing is done on an annual basis for men with a family history of prostate cancer.

The test is only recommended for men between the ages of 55 and 69. If you don’t have a family history of prostate cancer, and you get the PSA test, and it comes back high, a workup may be recommended. To find out if you have prostate cancer, a trans-rectal biopsy is performed. That means a Urologist or a prostate cancer specialist inserts an instrument into your butthole/rectum, and uses an instrument to take a piece of tissue from your prostate.

Because this biopsy is close to other important nerves and blood vessels that can control urine function and erectile function, this transrectal biopsy and other procedures to test for and treat prostate cancer can result in loss of urinary function and loss of erectile function.

You must know these facts before being tested for prostate cancer with a simple blood test.

From the United States Preventive Services Task Force:

For men aged 55 to 69 years, the decision to undergo periodic prostate-specific antigen (PSA)-based screening for prostate cancer should be an individual one. Before deciding whether to be screened, men should have an opportunity to discuss the potential benefits and harms of screening with their clinician and to incorporate their values and preferences in the decision. Screening offers a small potential benefit of reducing the chance of death from prostate cancer in some men. However, many men will experience potential harms of screening, including false-positive results that require additional testing and possible prostate biopsy; overdiagnosis and overtreatment; and treatment complications, such as incontinence and erectile dysfunction. In determining whether this service is appropriate in individual cases, patients and clinicians should consider the balance of benefits and harms on the basis of family history, race/ethnicity, comorbid medical conditions, patient values about the benefits and harms of screening and treatment-specific outcomes, and other health needs. Clinicians should not screen men who do not express a preference for screening.

I’ll repeat that information for emphasis: Screening offers a small potential benefit of reducing the chance of death from prostate cancer in some men. However, many men will experience potential harms of screening, including false-positive results that require additional testing and possible prostate biopsy; overdiagnosis and overtreatment; and treatment complications, such as incontinence and erectile dysfunction.

Thanks for reading, and we hope you take advantage of these screening tests, when appropriate.

-Dr. Paul Thomas with Plum Health DPC